Takeshi Ikeuchi

Prof. Takeshi Ikeuchi

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YZYingyue Zhou
Yingyue Zhou
WSWilbur M. Song
Wilbur M. Song
PAPrabhakar S. Andhey
Prabhakar S. Andhey
ASAmanda Swain
Amanda Swain
TLTyler Levy
Tyler Levy
MCMarco Colonna
Marco Colonna

29 September 2021 in Nature
Verified
Journal Article
Closed access
PDF file
YSYang Shi
Yang Shi
WZWenjuan Zhang
Wenjuan Zhang
YYYang Yang
Yang Yang
AMAlexey G. Murzin
Alexey G. Murzin
BFBenjamin Falcon
Benjamin Falcon
SSSjors H. W. Scheres
Sjors H. W. Scheres

11 March 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TNThe Dominantly Inherited Alzheimer Network
The Dominantly Inherited Alzheimer Network
NBNicolas R. Barthélemy
Nicolas R. Barthélemy
YLYan Li
Yan Li
NJNelly Joseph-Mathurin
Nelly Joseph-Mathurin
BGBrian A. Gordon
Brian A. Gordon
EMEric McDade
Eric McDade

12 February 2020 in Nature
Verified
Journal Article
Closed access
PDF file
WZWenjuan Zhang
Wenjuan Zhang
ATAiri Tarutani
Airi Tarutani
KNKathy L. Newell
Kathy L. Newell
AMAlexey G. Murzin
Alexey G. Murzin
TMTomoyasu Matsubara
Tomoyasu Matsubara
SSSjors H. W. Scheres
Sjors H. W. Scheres

7 August 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EJErik C. B. Johnson
Erik C. B. Johnson
SBShijia Bian
Shijia Bian
RHRafi U. Haque
Rafi U. Haque
ECE. Kathleen Carter
E. Kathleen Carter
CWCaroline M. Watson
Caroline M. Watson
ALAllan I. Levey
Allan I. Levey
Alzheimer’s disease (AD) pathology develops many years before the onset of cognitive symptoms. Two pathological processes—aggregation of the amyloid-β (Aβ) peptide into plaques and the microtubule protein tau into neurofibrillary tangles (NFTs)—are hallmarks of the disease. However, other pathological brain processes are thought to be key disease mediators of Aβ plaque and NFT pathology. How these additional pathologies evolve over the course of the disease is currently unknown. Here we show that proteomic measurements in autosomal dominant AD cerebrospinal fluid (CSF) linked to brain protein coexpression can be used to characterize the evolution of AD pathology over a timescale spanning six decades. SMOC1 and SPON1 proteins associated with Aβ plaques were elevated in AD CSF nearly 30 years before the onset of symptoms, followed by changes in synaptic proteins, metabolic proteins, axonal proteins, inflammatory proteins and finally decreases in neurosecretory proteins. The proteome discriminated mutation carriers from noncarriers before symptom onset as well or better than Aβ and tau measures. Our results highlight the multifaceted landscape of AD pathophysiology and its temporal evolution. Such knowledge will be critical for developing precision therapeutic interventions and biomarkers for AD beyond those associated with Aβ and tau.

29 September 2016 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
TKT. Konno
T. Konno
KYK. Yoshida
K. Yoshida
TMT. Mizuno
T. Mizuno
TKT. Kawarai
T. Kawarai
MTM. Tada
M. Tada
TITakeshi Ikeuchi
Takeshi Ikeuchi
Background and purpose: The clinical characteristics of colony stimulating factor 1 receptor (CSF1R) related adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) have been only partially elucidated.Methods: Clinical data from CSF1R mutation carriers who had been seen at our institutions or reported elsewhere were collected and analysed using a specific investigation sheet to standardize the data.Results: In all, 122 cases from 90 families with CSF1R mutations were identified. The mean age of onset was 43 years (range 18–78 years), the mean age at death was 53 years (range 23–84 years) and the mean disease duration was 6.8 years (range 1–29 years). Women had a significantly younger age of onset than men (40 vs. 47 years, P = 0.0006, 95% confidence interval 3.158–11.177). There was an age‐dependent penetrance that was significantly different between the sexes (P = 0.0013). Motor dysfunctions were the most frequent initial symptom in women whose diseases began in their 20s. Thinning of the corpus callosum, abnormal signalling in pyramidal tracts, diffusion‐restricted lesions and calcifications in the white matter were characteristic imaging findings of ALSP. The calcifications were more frequently reported in our case series than in the literature (54% vs. 3%). Seventy‐nine per cent of the mutations were located in the distal part of the tyrosine kinase domain of CSF1R (102 cases). There were no apparent phenotype−genotype correlations.Conclusions: The characteristics of ALSP were clarified. The phenotype of ALSP caused by CSF1R mutations is affected by sex.